Tectonic Therapeutic | Le Bénéfice D'Exploitation



Operating Profit Changement Date
Adcock Ingram Holdings ZAR 479.08M 106.67M 2024-06
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Celltrion KRW 207.69B 135.2B 2024-09
Cspc Pharmaceutical CNY 985M 796.94M 2024-09
Dianthus Therapeutics USD -29900000 7.7M 2024-09
Ecofibre AUD -4680000 38.98M 2024-06
Gilead Sciences USD 2.45B 1.56B 2024-12
Ionis Pharmaceuticals USD -110823000 37.83M 2024-12
Kangmei Pharma CNY -58945310 67.51M 2024-09
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Laboratorios Farma EUR 37.16M 17.88M 2024-06
MacroGenics USD 54.19M 112.37M 2024-09
Malin Corporation EUR -700000 1.6M 2024-06
Medical Developments International AUD -20243000 7.24M 2024-06
Neuren Pharmaceuticals AUD 176.69M 166.79M 2024-12
Organigram Holdings CAD -11305000 11.59M 2024-12
Pfizer USD -409000000 5.57B 2024-12
Pharma Mar EUR 4.89M 588K 2024-12
Qiagen NV USD 144.16M 14.73M 2024-12
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 4.09B 1.81B 2024-09
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Sartorius EUR 68.2M 38.1M 2024-09
Sino Biopharmaceutical CNY 1.73B 948.23M 2024-06
Takeda JPY 66.94B 117.3B 2024-12
Tilray USD -42218000 5.65M 2024-11
Zz Pientze Pharmaceu 1.13B 233.14M 2024-09



Tectonic Therapeutic Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.